NDC 0093-8199 – Sunitinib Malate
Sunitinib Malate 12.5 mg/1 · Capsule · Oral
Product NDC0093-8199
Product details
- Brand name
- Sunitinib Malate
- Generic name
- Sunitinib Malate
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA213803
- Marketed since
- December 22, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Sunitinib Malate 12.5 mg/1
Uses, dosage, side effects and warnings for Sunitinib Malate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0093-8199-28 | 28 CAPSULE in 1 BOTTLE (0093-8199-28) | Dec 22, 2021 |
Recalls mentioning this NDC
- D-0913-2023 Jul 19, 2023 · Class II
Failed Moisture Limits: Water (moisture) content above the approved product specifications.
Other Sunitinib Malate products
- 59651-465 Sunitinib Malate 25 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-466 Sunitinib Malate 37.5 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-467 Sunitinib Malate 50 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-464 Sunitinib Malate 12.5 mg/1 · Capsule · Aurobindo Pharma Limited
- 42291-904 Sunitinib Malate 50 mg/1 · Capsule · AvKARE
- 42291-903 Sunitinib Malate 37.5 mg/1 · Capsule · AvKARE
- 42291-901 Sunitinib Malate 12.5 mg/1 · Capsule · AvKARE
- 42291-902 Sunitinib Malate 25 mg/1 · Capsule · AvKARE
- 43598-045 Sunitinib Malate 12.5 mg/1 · Capsule · Dr.Reddys Laboratories Inc
- 43598-047 Sunitinib Malate 37.5 mg/1 · Capsule · Dr.Reddys Laboratories Inc
- 43598-046 Sunitinib Malate 25 mg/1 · Capsule · Dr.Reddys Laboratories Inc
- 43598-048 Sunitinib Malate 50 mg/1 · Capsule · Dr.Reddys Laboratories Inc